Gamified digital mental health interventions (DMHIs) may offer benefits for youth with attention-deficit/hyperactivity disorder (ADHD) or depressive disorder.

Topline results were announced from a trial evaluating dapirolizumab pegol in patients with moderate to severe systemic lupus erythematosus.

The age-adjusted suicide rate increased in 2021 and 2022, following a decline from 2018 to 2020, reaching 14.2 per 100,000 standard population in 2022.

Regional anesthesia may reduce chronic postsurgical pain up to 6 months and mitigate risk for persistent opioid use after elective noncardiac surgery.

Patients with RA face greater health care expenditures and a lower quality of life compared with the general population.

The FDA announced that it has accepted the supplemental sNDA for roflumilast foam 0.3% in those with scalp and body psoriasis over 12.

Emotion regulation and pain catastrophizing influenced pain severity and interference in patients taking opioid medications for chronic noncancer pain.

Childhood adversity is associated with worse biological health and an elevated risk for many major health problems.

For patients with type 2 diabetes (T2D) and opioid use disorder (OUD), semaglutide is associated with a significantly lower risk for opioid overdose compared with other antidiabetic medications.

For patients with obesity, the addition of semaglutide to standard hidradenitis suppurativa (HS) treatments yields improvement in quality of life and a reduction in flares.

While healthy diet quality is associated with reduced adverse cardiovascular and mortality outcomes, RA overpowers the benefits that may be attained through a healthy diet, resulting in the fact that ...

Study results published in Pediatric Rheumatology suggest that maintaining sufficient serum 25 (OH)-vitamin D levels could positively influence Kawasaki disease outcomes.